期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

腹膜后淋巴结清扫术治疗睾丸肿瘤6例分析

下载PDF
导出
摘要 目的探索腹膜后淋巴结清扫术（RPLND）对临床早期非精原细胞睾丸肿瘤的治疗效果和意义。方法对6例睾丸肿瘤患者完成睾丸切除术,择期再行RPLND后进行严密随访研究。其中2例患者根治性睾丸切除术后行保留神经RPLND。结果随访1~58个月,无瘤存活率100%,1例接受保留性神经改良清扫术后射精功能恢复满意。结论腹膜后淋巴结清扫术治疗临床早期睾丸非精原细胞肿瘤治愈率高,复发率低。
作者 潘晖 汪涛 熊鹰 钟光俊 呙林杰 成少平
机构地区 长江大学附属第一医院
出处 《现代中西医结合杂志》 CAS 2010年第33期4287-4288,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 腹膜后淋巴结清扫术 睾丸肿瘤 非精原细胞瘤
分类号 R737.21 [医药卫生—肿瘤]
  • 相关文献

参考文献9

  • 1Richie JP.Neoplasms of the testis//Walsh PC.Campbell's Urology[M].7th.Philadelphia:WB Saunders,1997:2411-2452.
  • 2Choueiri TK,Stephenson AJ,Gilligan T,et al.Management of clinical stage I nonseminomatous germ cell testicular cancer[J].Urol Clin North Am,2007,34:137-148.
  • 3Jewett MAS,Groll RJ.Nerve-sparing retroperitoneal lymphadenectomy[J].Urol Clin North Am,2007,34:149-158.
  • 4Schmoll HJ,Souchon R,Krege S,et al.European consensus on diagnosis and treatment of germ cell cancer:a report of the European Germ Cell Cancer Consensus Group (EGCCCG)[J].Ann Oncol 2004,15:1377-1382.
  • 5Albers P,Albrecht W,Algaba F,et al.Guidelines on testicular cancer[J].Eur Urol,2005,48(6):885-894.
  • 6Albers P,Siener R,Kliesch S,et al.Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors:results of the German Testicular Cancer Study Group Trial[J].J Clin Oncol 2003,21:1505-1512.
  • 7Hao D,Seidel J,Brant R,et al.Compliance of clinical stage I nonseminomatous germ cell tumor patients with surveillance[J].J Urol,1998,160:768-771.
  • 8Stephenson AJ,Sheinfeld J.Management of patients with low-stage nonseminomatous germ cell testicular cancer[J].Curr Treat Options Oncol,2005,6(5):367-377.
  • 9叶定伟,方银忠,戴波,顾卫列,刘守业.睾丸肿瘤腹膜后淋巴结清扫术39例报告[J].中华泌尿外科杂志,2005,26(4):283-285. 被引量：10

二级参考文献12

  • 1梅骅.睾丸肿瘤后腹膜淋巴结清除术[A].见:郭应禄主编.泌尿、男生殖系肿瘤[C].北京:人民卫生出版社,2000.396-407.
  • 2Rabbani F, Sheinfeld J, Farivar-Mohseni H, et al. Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse. J Clin Oncol,2001,19:2020-2025.
  • 3Roeleveld TA, Horenblas S, Meinhardt W, et al. Surveillance can be the standard of care for stage I nonseminomatous testieular tumors and even high risk patients..1 Uro1,2001,166 :2166-2170.
  • 4Segal R, Lukka H, Klotz LH, et al. Surveillance programs for early stage non-seminomatous testicular cancer: a practice guideline. Can J Urol,2001,8 : 1184-1192.
  • 5Sheinfeld J. The role of adjunctive postchemotherapy surgery for nonseminomatous germ-cell tumors : current concepts and controversies.Semin Urol 0ncol,2002,20:262-271.
  • 6Daugaard G, Petersen PM, Rorth M. Surveillance in stage I testicular cancer. APMIS ,2003,111:76-83.
  • 7Spermon JR, Roeleveld TA, van der Poel HG, et al. Comparison of surveillance and retroperitoneal lymph node dissection in Stage I nonseminomatous germ cell tumors. Urology,2002,59:923-929.
  • 8Albers P, Siener R, Kliesch S, eta]. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors : results of the German Testicular Cancer Study Group Trial. J Clin 0ncol,2003,21:1505-1512.
  • 9Kondagunta GV, Motzer RJ Adjuvant chemotherapy for stage Ⅱ nonseminomatous germ-cell tumors. Semin Urol Oneol, 2002,20 : 239-243.
  • 10Behnia M,Foster R, Einhorn LH,et al. Adjuvant bleomycin, etoposide and cisplatin in pathological stage Ⅱ non-seminomatous testieular cancer, the Indiana University experience. Eur J Cancer,2000,36:472-475.

共引文献9

现代中西医结合杂志
2010年 第33期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部